EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency

Jade Jansen, Killian E Vlaming, Leanne C Helgers, Eva Schumacher, Tanja M Kaptein, Rogier W Sanders, Godelieve J de Bree, Teunis B H Geijtenbeek, Neeltje A Kootstra iD

PLOS One · 20.07.2026 · 21 (7) · e0348959

DOI: 10.1371/journal.pone.0348959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.07.2026. Verfasst von Jade Jansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Lipid A, HIV-1, Virus Latency, Adjuvants, Immunologic. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health~Holland, zonmw, Aidsfonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monophosphoryl lipid A (MPLA) and the saponin-MPLA nanoparticle adjuvant (SMNP) are known immunostimulants used as adjuvants in vaccines to boost immunity. These adjuvants are under investigation for use in prophylactic and therapeutic HIV-1 vaccines. However, their effects in ART-treated people with HIV-1 (PWH) remain unclear, as chronic immune activation may reduce responses and potentially reactivate latent virus reservoirs. Here we observed that both adjuvants, MPLA and SMNP, triggered TLR4‑dependent cytokine production in monocyte-derived dendritic cells (DCs), but SMNP elicited a stronger response than MPLA based on costimulatory receptor expression and cytokine production. Cytokines produced by adjuvant stimulated dendritic cells were able to induce HIV-1 transcription in a J-Lat cell model. Notably, SMNP, but not MPLA, also induced a cytokine response in PBMC from PWH, albeit lower as compared to in healthy donor PBMC. Importantly, SMNP substantially reduced the size of the inducible HIV‑1 reservoir in PWH ex vivo . The effect on the viral reservoir was likely caused by the cytokine production induced by SMNP, as supernatants from SMNP stimulated DCs showed a similar viral reservoir reduction. Our findings demonstrate that TLR4-targeted adjuvants, especially SMNP, can effectively induce immune activation, supporting their potential use in therapeutic vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid AHIV-1Virus LatencyAdjuvants, ImmunologicSaponinsHIV InfectionsHumansDendritic CellsCytokinesNanoparticlesToll-Like Receptor 4Toll-Like Receptor AgonistsAIDS Vaccines

Substanzen

Lipid Amonophosphoryl lipid AAdjuvants, ImmunologicSaponinsCytokinesToll-Like Receptor 4Toll-Like Receptor AgonistsAIDS Vaccines

Autor:innen und Institutionen

  • Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands.
  • Amsterdam institute for infectious diseases and immunology, Amsterdam, The Netherlands.
  • Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands.
  • Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, United States of America.
  • Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands.

ORCID-Profile: Neeltje A Kootstra

Förderung

  • Health~Holland
  • zonmw
  • Aidsfonds
  • Aids Fonds

Zitieren

APA

Jansen, J., Vlaming, K. E., Helgers, L. C., Schumacher, E., Kaptein, T. M., Sanders, R. W., de Bree, G. J., Geijtenbeek, T. B. H., & Kootstra, N. A. (2026). Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency. PLOS One, 21(7), e0348959. https://doi.org/10.1371/journal.pone.0348959

Vancouver

Jansen J, Vlaming KE, Helgers LC, Schumacher E, Kaptein TM, Sanders RW, et al. Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency. PLOS One. 2026;21(7):e0348959. doi:10.1371/journal.pone.0348959

BibTeX
@article{Jansen2026,
  author = {Jansen, Jade and Vlaming, Killian E and Helgers, Leanne C and Schumacher, Eva and Kaptein, Tanja M and Sanders, Rogier W and de Bree, Godelieve J and Geijtenbeek, Teunis B H and Kootstra, Neeltje A},
  title = {Adjuvants MPLA and SMNP induce antiviral immunity and indirectly revert HIV-1 latency},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0348959},
  doi = {10.1371/journal.pone.0348959}
}
Kostenlos starten →